Coronary/Structural Heart

Teleflex to Introduce the New Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump and the Product Portfolio from the Recently Acquired Vascular Solutions, Inc. at the European Association for Percutaneous Cardiovascular Interventions Course (EuroPCR)

WAYNE, Pa.–(BUSINESS WIRE)–May 15, 2017– Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase its complex PCI product portfolio recently acquired from the purchase of Vascular Solutions and the new […]

Edwards Lifesciences (EW)’ Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes

PARIS, May 17, 2017 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced late-breaking data at EuroPCR 2017 demonstrating excellent clinical outcomes for transcatheter aortic valve replacement […]

Acist Medical Systems, Inc. Release: Head-to-Head Study Validates Consistent Performance Of Microcatheter FFR

PARIS & EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–ACIST Medical Systems Inc., a Bracco Group Company, today announced results from the ACIST-FFR Study (Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve measurement) demonstrating the consistent and correlative performance of the […]

Elixir Medical Announces Outstanding 5-Year Clinical Data For CE Mark-Approved Desolve Novolimus Eluting Bioresorbable Coronary Scaffold System

MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, today announced excellent 5-year clinical data from the DESolve Nx international pivotal clinical trial for the CE Mark-approved, fully bioresorbable DESolve® Novolimus Eluting […]

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

LAKE FOREST, Calif.–(BUSINESS WIRE)–NaviGate Cardiac Structures Inc. (“NCSI”) announced today that the GATE™ catheter-guided tricuspid atrioventricular valved stent (AVS) was implanted through the jugular vein one week ago in a patient suffering from severe tricuspid regurgitation stemming from two failed […]

Daiichi Sankyo Initiates ENVISAGE-TAVI AF Study Investigating Once-Daily LIXIANA®▼ (edoxaban) in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation

MUNICH, April 27, 2017 /PRNewswire/ — ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on clinical outcomes exclusively in atrial fibrillation patients following successful transcatheter aortic valve implantation Study adds to the growing […]

LivaNova (LIVN) Takes Out Caisson Interventional in $72 Million Deal

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it has acquired the remaining outstanding interests in Caisson Interventional, LLC (“Caisson”), in support of LivaNova’s strategic growth initiatives. Based in Maple Grove, Minn., Caisson […]